REQUEST A DEMO
Total
USD $0.00
Search more companies

Balance Pharma S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Balance Pharma S.A.S. Profile Updated: March 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Balance Pharma S.A.S. is an enterprise located in Colombia, with the main office in Envigado. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was established on July 27, 2021. It currently has a total number of 17 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 97.85% in 2023. Its total assets grew by 43.27% over the same period. In 2023, Balance Pharma S.A.S.’s net profit margin increased by 8.34%.

Headquarters
Cl 49 Sur # 43A 30
Envigado; Antioquia;

Contact Details: Purchase the Balance Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Balance Pharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Balance Pharma S.A.S. report to view the information.
Incorporation Date:
July 27, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Balance Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
97.85%
Total operating revenue
97.85%
Net Profit (Loss) for the Period
199.52%
Total assets
43.27%
Total equity
1088.79%
Net Profit Margin
8.34%
Return on Equity (ROE)
-367.29%
Quick Ratio
0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?